Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2026 07:00 ET | Source: MitoRx Therapeutics Limited

MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions

Poster to be presented at ADA 2026 on weight loss induced by MTRX31 in an industry-standard preclinical model of obesityMitoRx Chief Scientific Officer Xavier Jacq to also participate in panel and...